MS On Sun Pharma
OW, TP Rs 505
Cequa Adds On To Its In-market NDA Products Ilumya, Absorica, Bromsite
Cequa Is Third Product In Its Ophthalmic Portfolio
Estimate $40-60 m In Revenues For Cequa Over The Next Couple Of Months